Patient Guide: Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 106 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT00099437
Status: ACTIVE_NOT_RECRUITING
Condition: Breast Cancer
Phase: PHASE3

Where You Can Participate

This study is available at 106 locations across the country.

Top locations include:
  • • Casa Grande, Arizona
  • • Fountain Valley, California
  • • New Britain, Connecticut
  • • And 103 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy. - Join Clinical Trial NCTNCT00099437

How to Join This Clinical Trial - NCTNCT00099437

Learn how to participate in this PHASE3 trial studying an investigational therapy for Breast Cancer. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Breast Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Breast Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT00099437 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 106 locations. Find a study site near you:

Clinical Research Site

Casa Grande, Arizona 85122 - United States

Status: Contact for availability

Clinical Research Site

Fountain Valley, California 92708 - United States

Status: Contact for availability

Clinical Research Site

New Britain, Connecticut 06052 - United States

Status: Contact for availability

Clinical Research Site

Crystal River, Florida 34429 - United States

Status: Contact for availability

Clinical Research Site

Fort Lauderdale, Florida 33308 - United States

Status: Contact for availability

Clinical Research Site

Urbana, Illinois 61801 - United States

Status: Contact for availability

Clinical Research Site

Rosedale, Maryland 21237 - United States

Status: Contact for availability

Clinical Research Site

Detroit, Michigan 48202 - United States

Status: Contact for availability

Clinical Research Site

Kansas City, Missouri 64131 - United States

Status: Contact for availability

Clinical Research Site

Saint Louis, Missouri 63141 - United States

Status: Contact for availability

And 96 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Breast Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships